伊朗风湿关节炎的经济负担:一个社会视角
Mehdi Rezaee1,2, Farhad Lotfi3, Ahmad Gholami4,5
1Department of Management, Economics and Health Policy, School of Health Bushehr University of Medical Sciences Bushehr Iran.
Public health challenges
|November 14, 2025
概括
在2022年,伊朗的类风湿性关节炎 (RA) 的经济负担为每名患者每年6388.64美元. 直接的医疗成本,特别是药物,是这种对患者和社会的重大财务影响的主要驱动因素.
科学领域:
- 卫生经济学 卫生经济学
- 类风湿病学 类风湿病学
- 公共卫生 公共卫生
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性,全身性炎症性疾病,具有重大经济影响.
- 无法控制的RA对患者和医疗保健系统造成重大负担.
- 了解经济负担对于有效管理和资源分配至关重要.
研究的目的:
- 量化伊朗风湿性关节炎 (RA) 的总经济负担.
- 确定与伊朗背景下的RA管理相关的关键成本驱动因素.
- 提供基于数据的建议,以减轻RA的经济影响.
主要方法:
- 在2022年进行了一项横截面研究,涉及765名RA患者.
- 基于流行和自下而上的方法被用于成本估计.
- 人力资本方法用于计算间接成本.
主要成果:
- 伊朗RA的整体经济负担在2022年估计为每名患者每年6388.64美元.
- 平均每年RA成本因疾病状态而异:$ 6268.24 (缓解),$ 6248.00 (低),和$ 6729.43 (中度至重度).
- 直接医疗费用,特别是药品费用,是最重要的组成部分.
结论:
- 类风湿性关节炎给伊朗患者和社会带来了相当大的经济负担.
- 降低经济负担需要采取战略,例如国内生产RA药物和加强家庭护理服务.
- 政策干预应侧重于优化药物可用性和护理提供模式.
相关概念视频
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Rheumatic Heart Disease I: Introduction
415
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
415
Rheumatic Heart Disease III: Medical Management
272
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
272
Rheumatic Heart Disease IV: Nursing Management
256
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
256
Factors Affecting Illness
5.0K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
5.0K
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K


